Crystal structure of the SOCS2–elongin C–elongin B complex defines a prototypical SOCS box ubiquitin ligase
暂无分享,去创建一个
Stefan Knapp | Aled M. Edwards | S. Knapp | J. Debreczeni | M. Sundström | A. Bullock | Alex N. Bullock | Michael Sundström | Judit É. Debreczeni | A. Edwards
[1] D. Waxman,et al. Interaction of Growth Hormone-activated STATs with SH2-containing Phosphotyrosine Phosphatase SHP-1 and Nuclear JAK2 Tyrosine Kinase* , 1997, The Journal of Biological Chemistry.
[2] S. Elledge,et al. Structure of the Cul1–Rbx1–Skp1–F boxSkp2 SCF ubiquitin ligase complex , 2002, Nature.
[3] D E McRee,et al. XtalView/Xfit--A versatile program for manipulating atomic coordinates and electron density. , 1999, Journal of structural biology.
[4] F. Giordanetto,et al. A three-dimensional model of Suppressor Of Cytokine Signalling 1 (SOCS-1). , 2003, Protein engineering.
[5] Keiichi I Nakayama,et al. VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases. , 2004, Genes & development.
[6] Collaborative Computational,et al. The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.
[7] W. Kaelin,et al. Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function. , 1999, Science.
[8] A. Kibel,et al. Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C , 1995, Science.
[9] G. Murshudov,et al. Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.
[10] Ruben Abagyan,et al. ICM—A new method for protein modeling and design: Applications to docking and structure prediction from the distorted native conformation , 1994, J. Comput. Chem..
[11] J. Kopchick,et al. Transgenic models of growth hormone action. , 1999, Annual review of nutrition.
[12] P. van Kerkhof,et al. The ubiquitin-proteasome pathway regulates the availability of the GH receptor. , 2002, Endocrinology.
[13] H. Pendeville,et al. SOCS3 Is Essential in the Regulation of Fetal Liver Erythropoiesis , 1999, Cell.
[14] Randy J Read,et al. Electronic Reprint Biological Crystallography Likelihood-enhanced Fast Rotation Functions Biological Crystallography Likelihood-enhanced Fast Rotation Functions , 2003 .
[15] S. Horvat,et al. Lack of Socs2 expression causes the high-growth phenotype in mice. , 2001, Genomics.
[16] Kevin Cowtan,et al. research papers Acta Crystallographica Section D Biological , 2005 .
[17] R. Black,et al. Tumor Necrosis Factor-α Converting Enzyme (TACE) Is a Growth Hormone Binding Protein (GHBP) Sheddase: The Metalloprotease TACE/ADAM-17 Is Critical for (PMA-Induced) GH Receptor Proteolysis and GHBP Generation. , 2000, Endocrinology.
[18] W. Alexander,et al. Gigantism in mice lacking suppressor of cytokine signalling-2 , 2000, Nature.
[19] R. Klausner,et al. Identification of the von Hippel-lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[20] D. Waxman,et al. SOCS/CIS Protein Inhibition of Growth Hormone-stimulated STAT5 Signaling by Multiple Mechanisms* , 1999, The Journal of Biological Chemistry.
[21] Stephen J. Elledge,et al. Insights into SCF ubiquitin ligases from the structure of the Skp1–Skp2 complex , 2000, Nature.
[22] R. Norton,et al. Secondary structure assignment of mouse SOCS3 by NMR defines the domain boundaries and identifies an unstructured insertion in the SH2 domain , 2005, The FEBS journal.
[23] G. Norstedt,et al. Negative regulation of growth hormone receptor signaling. , 2006, Molecular endocrinology.
[24] A. Elefanty,et al. Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[25] M. Gstaiger,et al. The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activity. , 1999, Genes & development.
[26] E. Hooghe-Peters,et al. Suppressor of Cytokine Signaling 7 Inhibits Prolactin, Growth Hormone, and Leptin Signaling by Interacting with STAT5 or STAT3 and Attenuating Their Nuclear Translocation* , 2005, Journal of Biological Chemistry.
[27] S. Asa,et al. Growth enhancement in suppressor of cytokine signaling 2 (SOCS-2)-deficient mice is dependent on signal transducer and activator of transcription 5b (STAT5b). , 2002, Molecular endocrinology.
[28] J. Kutok,et al. Socs-1 Inhibits TEL-JAK2-Mediated Transformation of Hematopoietic Cells through Inhibition of JAK2 Kinase Activity and Induction of Proteasome-Mediated Degradation , 2001, Molecular and Cellular Biology.
[29] Perry F. Bartlett,et al. Suppressor of cytokine signaling 2 regulates neuronal differentiation by inhibiting growth hormone signaling , 2002, Nature Neuroscience.
[30] Claes Ohlsson,et al. SOCS2 negatively regulates growth hormone action in vitro and in vivo. , 2005, The Journal of clinical investigation.
[31] P. van Kerkhof,et al. The Signal Transduction of the Growth Hormone Receptor Is Regulated by the Ubiquitin/Proteasome System and Continues After Endocytosis* , 2001, The Journal of Biological Chemistry.
[32] J. Johnston,et al. Tyrosine Phosphorylation Disrupts Elongin Interaction and Accelerates SOCS3 Degradation* , 2003, Journal of Biological Chemistry.
[33] W. Alexander,et al. SOCS-6 Binds to Insulin Receptor Substrate 4, and Mice Lacking the SOCS-6 Gene Exhibit Mild Growth Retardation , 2002, Molecular and Cellular Biology.
[34] A. Colao,et al. Extensive personal experience: Acromegaly , 1997 .
[35] D. Waxman,et al. Role of the Cytokine-induced SH2 Domain-containing Protein CIS in Growth Hormone Receptor Internalization* , 2005, Journal of Biological Chemistry.
[36] W. Alexander,et al. The SOCS box: a tale of destruction and degradation. , 2002, Trends in biochemical sciences.
[37] A. Yoshimura,et al. The JAK‐binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop , 1999, The EMBO journal.
[38] Jan Tavernier,et al. Design and application of a cytokine-receptor-based interaction trap , 2001, Nature Cell Biology.